Home Cart 0 Sign in  
X

[ CAS No. 59997-51-2 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 59997-51-2
Chemical Structure| 59997-51-2
Chemical Structure| 59997-51-2
Structure of 59997-51-2 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 59997-51-2 ]

Related Doc. of [ 59997-51-2 ]

Alternatived Products of [ 59997-51-2 ]

Product Details of [ 59997-51-2 ]

CAS No. :59997-51-2 MDL No. :MFCD00010208
Formula : C7H11NO Boiling Point : -
Linear Structure Formula :- InChI Key :MXZMACXOMZKYHJ-UHFFFAOYSA-N
M.W : 125.17 Pubchem ID :108871
Synonyms :

Calculated chemistry of [ 59997-51-2 ]

Physicochemical Properties

Num. heavy atoms : 9
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.71
Num. rotatable bonds : 2
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 35.45
TPSA : 40.86 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.18 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.3
Log Po/w (XLOGP3) : 1.24
Log Po/w (WLOGP) : 1.52
Log Po/w (MLOGP) : 0.71
Log Po/w (SILICOS-IT) : 1.15
Consensus Log Po/w : 1.18

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.27
Solubility : 6.8 mg/ml ; 0.0543 mol/l
Class : Very soluble
Log S (Ali) : -1.7
Solubility : 2.52 mg/ml ; 0.0201 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.49
Solubility : 4.08 mg/ml ; 0.0326 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.42

Safety of [ 59997-51-2 ]

Signal Word:Danger Class:6.1
Precautionary Statements:P264-P270-P301+P310+P330-P405-P501 UN#:3439
Hazard Statements:H301 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 59997-51-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 59997-51-2 ]
  • Downstream synthetic route of [ 59997-51-2 ]

[ 59997-51-2 ] Synthesis Path-Upstream   1~33

  • 1
  • [ 59997-51-2 ]
  • [ 59669-59-9 ]
YieldReaction ConditionsOperation in experiment
76% With sodium hydroxide; hydroxylamine hydrochloride In water at 50℃; for 3 h; To an aqueous solution of sodium hydroxide solution (40.00 g, 1 mol, in 200 ml of water) was added hydroxylamine hydrochloride (24.00 g, 346 mmol) and pivaloylacetonitrile (40.00 g, 320 mmol).
The resulting solution was stirred at 50° C. for 3 hrs.
The reaction mixture cooled and the resultant white crystalline solid filtered, washed with water and dried to provide 3-t-butylisoxazol-5-amine as a white crystalline solid (34 g, yield 76percent yield).
1H NMR (DMSO-d6) δ 6.41 (brs, 2H), 4.85 (s, 1H), 1.18(s, 9H): LC-MS (ES, m/z, M+H) 141.3.
Reference: [1] Heterocycles, 1991, vol. 32, # 6, p. 1153 - 1158
[2] Journal of Medicinal Chemistry, 2012, vol. 55, # 3, p. 1082 - 1105
[3] Patent: US2008/261961, 2008, A1, . Location in patent: Page/Page column 16
[4] Organic Letters, 2018, vol. 20, # 9, p. 2774 - 2777
[5] Journal of Medicinal Chemistry, 2016, vol. 59, # 18, p. 8293 - 8305
[6] Chemische Berichte, 1932, vol. 65, p. 1857,1862
[7] Bioorganic and Medicinal Chemistry Letters, 2000, vol. 10, # 18, p. 2047 - 2050
[8] Patent: WO2010/77836, 2010, A2, . Location in patent: Page/Page column 131
[9] Molecules, 2014, vol. 19, # 2, p. 2004 - 2028
[10] Bioorganic and Medicinal Chemistry Letters, 2015, vol. 25, # 17, p. 3436 - 3441
  • 2
  • [ 59997-51-2 ]
  • [ 59669-59-9 ]
  • [ 121449-41-0 ]
Reference: [1] Dyes and Pigments, 2010, vol. 86, # 1, p. 42 - 49
  • 3
  • [ 59997-51-2 ]
  • [ 55809-36-4 ]
YieldReaction ConditionsOperation in experiment
94.5% With hydrogenchloride; sodium hydroxide; hydroxylamine sulfate; triethylamine In methanol; toluene EXAMPLE 1
To a suspension of cyanopinacolone (75.102 g) in a mixture of anhydrous toluene (150 ml) and anhydrous methanol (26.7 ml) is introduced gaseous hydrogen chloride (26.3 g) with cooling at 5° to 10° C. and stirring, and the whole mixture is allowed to stand at 10° to 12° C. for 23 hours.
To the reaction mixture is dropwise added anhydrous methanol (750 ml), then triethylamine (185.178 g) with cooling and stirring to make a complete solution.
The reaction mixture is treated with hydroxylamine sulfate (51.704 g) and stirred at 50° C. for 2 hours.
Then, conc. hydrochloric acid (112.629 g) is dropwise added to the mixture, which is stirred at 50° C. for 1 hour.
After evaporating the solvent under reduced pressure from the reaction mixture, the residue is made alkaline with 48percent aqueous sodium hydroxide with cooling, and the aqueous solution is shaken with toluene.
The organic layer is washed with water, subjected to azeotropic distillation under atmospheric pressure, and evaporated to dryness to remove the solvent, whereby 3-amino-5-t-butylisoxazole (79.480 g) is obtained.
Melting point is 106° to 109° C.
Yield is 94.5percent.
77% With hydroxylamine hydrochloride; sodium hydroxide In water at 20℃; for 0.5 h; 4,4-dimethyl-3-oxopentanenitrile (3 g, 23.97 mmol) was dissolved in distilled water, stirred, and added with NaOH (1.06 g, 26.4 mmol) and NH2OH-HCl (1.83 g, 26.4 mmol). The reaction solution was stirred for about 30 minutes at room temperature. The reaction mixture was calibrated to yield pH in a range of 8 to 9 by adding an aqueous solution of 1 N NaOH, followed by further stirring for 10 hours or more at 50°C. The reaction mixture was washed 2 to 3 times with carbon tetrachloride, and aqueous layer was calibrated to yield pH in a range of 4 to 5 by adding concentrated HC1. The reaction mixture was further stirred for about 3 hours at 50°C. The reaction mixture was cooled to room temperature, and calibrated to yield pH 12 by adding an aqueous solution of 1 N NaOH. The resulting solid was filtered under reduced pressure, and washed with distilled water. The filtered solid was dried with warm wind in an oven (40°C) for 3 hours or more to obtain the title compound (2.6 g, 77percent). -NMR Spectrum (300 MHz, DMSO-i: δ 5.49 (s, 1H), 5.40 (s, 2H), 1.21 (s, 9H) MS(ESI+, m/z): 141 [M+H]+
77%
Stage #1: With hydroxylamine hydrochloride; sodium hydroxide In water at 20℃; for 0.5 h;
Stage #2: With sodium hydroxide In water at 50℃;
4,4-dimethyl-3-oxopentanenitrile (3 g, 23.97 mmol) was dissolved in distilled water, stirred, and added with NaOH (1.06 g, 26.4 mmol) and NH2OH.HCl (1.83 g, 26.4 mmol). The reaction solution was stirred for about 30 minutes at room temperature. The reaction mixture was calibrated to yield pH in a range of 8 to 9 by adding an aqueous solution of 1 N NaOH, followed by further stirring for 10 hours or more at 50° C. The reaction mixture was washed 2 to 3 times with carbon tetrachloride, and aqueous layer was calibrated to yield pH in a range of 4 to 5 by adding concentrated HCl. The reaction mixture was further stirred for about 3 hours at 50° C. The reaction mixture was cooled to room temperature, and calibrated to yield pH 12 by adding an aqueous solution of 1 N NaOH. The resulting solid was filtered under reduced pressure, and washed with distilled water. The filtered solid was dried with warm wind in an oven (40° C.) for 3 hours or more to obtain the title compound (2.6 g, 77percent). 1H-NMR Spectrum (300 MHz, DMSO-d6): δ 5.49 (s, 1H), 5.40 (s, 2H), 1.21 (s, 9H) MS (ESI+, m/z): 141 [M+H]+
70% With hydroxylamine hydrochloride; sodium hydroxide In water at 25℃; for 0.5 h; To a solution of pivaloylacetonitrile (3 g, 23.97 mmol) in water (20 mL), NaOH (1.06 g, 26.4 mmol) and hydroxylamine hydrochloride (1.83 g, 26.4 mmol) were added continuously with stirring. The resulting solution was stirred for approximately 30 min at room temperature, and the pH adjusted to 10–11 with 1 M NaOH. After stirring for 10 h or more at 50 °C, the mixture was cooled and washed two to three times with carbon tetrachloride. The aqueous layer was acidified with concentrated HC1 until the pH = 4–5, and then further stirred for approximately 3 h at 50 °C. The reaction mixture was cooled to room temperature, and adjusted to pH 12 by adding an aqueous solution of 1 N NaOH. The resulting solid was filtered, washed with distilled water, and driedin air to obtain compound 25s as a white solid (2.0 g, yield: 70percent).
84.74%. With hydrogenchloride; sodium hydroxide; hydroxylamine hydrochloride In ethanol EXAMPLE 1
In a mixture of pivaloylacetonitrile (25.03 g) and 50percent (v/v) ethanol (400 ml) is dissolved 96percent sodium hydroxide (9.583 g).
To this solution is added hydroxylamine hydrochloride (purity, 96percent) at 27° C. to give a solution (pH 7.8), which is stirred at 60° C. for 22 hours.
The reaction mixture is cooled at 20° C., mixed with conc. hydrochloric acid (9.11 g), and stirred at 50° C. for 2 hours. Conc. hydrochloric acid (14.18 g) is added to the mixture, which is refluxed at 100° C. for 1 hour.
The reaction mixture is concentrated under reduced pressure to remove ethanol and the residue is mixed with 30percent sodium hydroxide (62 g).
The mixture is shaken with chloroform.
The chloroform layer is washed with water, dried over anhydrous sodium sulfate and concentrated under reduced pressure to give 3-amino-5-t-butylisoxazole (23.76 g).
Yield, 84.74percent. m.p. 101-109.5° C. Purity, 95.1percent.

Reference: [1] Patent: US4200757, 1980, A,
[2] Patent: WO2013/100632, 2013, A1, . Location in patent: Page/Page column 42; 43
[3] Patent: US2014/371219, 2014, A1, . Location in patent: Paragraph 0288; 0289; 0290
[4] Molecules, 2014, vol. 19, # 2, p. 2004 - 2028
[5] Heterocycles, 1991, vol. 32, # 6, p. 1153 - 1158
[6] Patent: US4256899, 1981, A,
[7] Patent: US4500345, 1985, A,
[8] Journal of Medicinal Chemistry, 2016, vol. 59, # 18, p. 8293 - 8305
  • 4
  • [ 59997-51-2 ]
  • [ 55809-36-4 ]
  • [ 75914-61-3 ]
Reference: [1] Heterocycles, 1991, vol. 32, # 6, p. 1153 - 1158
  • 5
  • [ 59997-51-2 ]
  • [ 55809-36-4 ]
  • [ 136320-07-5 ]
  • [ 75914-61-3 ]
Reference: [1] Heterocycles, 1991, vol. 32, # 6, p. 1153 - 1158
  • 6
  • [ 598-98-1 ]
  • [ 75-05-8 ]
  • [ 59997-51-2 ]
YieldReaction ConditionsOperation in experiment
51%
Stage #1: With sodium hydride In 1,4-dioxane; paraffin oil (nujol) for 0.75 h;
Stage #2: for 3 h; Reflux
NaH (50 percent in paraffin oil) (1.2 eq., 4.6 g) was dissolved in 1 ,4-dioxane (120 ml) and the mixture was stirred for a few minutes. Acetonitrile (1.2 eq., 4.2 g) was added dropwise within 15 min and the mixture was stirred for a further 30 min. The methyl pivalate (J-I) (1 eq., 10 g) was added dropwise within 15 min and the reaction mixture was refluxed for 3 h. After complete reaction, the reaction mixture was placed in iced water (200 g), acidified to pH 4.5 and extracted with dichloromethane (12 x 250 ml). The combined organic phases were dried over sodium sulphate, distilled and after recrystallisation from hexane (100 ml) 5 g of the product (J-Il) (51 percent yield) was able to be obtained as a solid brown substance.
51%
Stage #1: With sodium hydride In 1,4-dioxane; paraffin oil (nujol) for 0.75 h;
Stage #2: for 3 h; Reflux
NaH (50 percent in paraffin oil) (1.2 eq., 4.6 g) was dissolved in 1 ,4-dioxane (120 ml) and the mixture was stirred for a few minutes. Acetonitrile (1.2 eq., 4.2 g) was added dropwise within 15 min and the mixture was stirred for a further 30 min. The methyl pivalate (J-I) (1 eq., 10 g) was added dropwise within 15 min and the reaction mixture was refluxed for 3 h. After complete reaction, the reaction mixture was placed in iced water (200 g), acidified to pH 4.5 and extracted with dichloromethane (12 x 250 ml). The combined organic phases were dried over sodium sulphate, distilled and after recrystallisation from hexane (100 ml) 5 g of the product (J-Il) (51 percent yield) was able to be obtained as a solid brown substance.
51%
Stage #1: With sodium hydride In 1,4-dioxane; paraffin oil for 0.75 h;
Stage #2: for 3 h; Reflux
NaH (50percent in paraffin oil) (1.2 equiv., 4.6 g) was dissolved in 1,4-dioxane (120 mL) and stirred for a few minutes. Acetonitrile (1.2 equiv., 4.2 g) was added dropwise within 15 min and the mixture was stirred for a further 30 min. The methyl pivalate (J-I) (1 equiv., 10 g) was added dropwise within 15 min and the reaction mixture was refluxed for 3 h. After complete conversion the reaction mixture was poured into iced water (200 g), acidified to pH 4.5, and extracted with dichloromethane (12.x.250 mL). The combined organic phases were dried over sodium sulphate, distilled, and after recrystallisation from hexane (100 mL) 5 g of the product (J-II) (51percent yield) was obtained as a brown solid substance.
51%
Stage #1: With sodium hydride In 1,4-dioxane; paraffin oil (nujol) for 0.75 h;
Stage #2: Reflux
Step j02: NaH (50percent in paraffin oil) (1.2 eq., 4.6 g) was dissolved in 1,4-dioxane (120 ml) and the mixture was stirred for a few minutes. Acetonitrile (1.2 eq., 4.2 g) was added dropwise within 15 min and the mixture was stirred for a further 30 min. The methyl pivalate (J-I) (1 eq., 10 g) was added dropwise within 15 min and the reaction mixture was refluxed for 3 h. After complete reaction, the reaction mixture was placed in iced water (200 g), acidified to pH 4.5 and extracted with dichloromethane (12.x.250 ml). The combined organic phases were dried over sodium sulphate, distilled and after recrystallisation from hexane (100 ml) 5 g of the product (J-II) (51percent yield) was able to be obtained as a solid brown substance.
51%
Stage #1: With sodium hydride In 1,4-dioxane; paraffin oil (nujol) for 0.75 h;
Stage #2: for 3.25 h; Reflux
NaH (50 percent in paraffin oil) (1.2 eq., 4.6 g) was dissolved in 1 ,4-dioxane (120 ml) and the mixture was stirred for a few minutes. Acetonitrile (1.2 eq., 4.2 g) was added dropwise within 15 min and the mixture was stirred for a further 30 min. The methyl pivalate (J-l) (1 eq., 10 g) was added dropwise within 15 min and the reaction mixture was refluxed for 3 h. After complete reaction, the reaction mixture was placed in iced water (200 g), acidified to pH 4.5 and extracted with dichloromethane (12 x 250 ml). The combined organic phases were dried over sodium sulphate, distilled and after recrystallisation from hexane (100 ml) 5 g of the product (J-ll) (51 percent yield) was able to be obtained as a solid brown substance
51%
Stage #1: With sodium hydride In 1,4-dioxane; paraffin oil (nujol) for 0.5 h;
Stage #2: for 3 h; Reflux
Step j02: NaH (50percent in paraffin oil) (1.2 eq., 4.6 g) was dissolved in 1,4-dioxane (120 ml) and the mixture was stirred for a few minutes. Acetonitrile (1.2 eq., 4.2 g) was added dropwise within 15 min and the mixture was stirred for a further 30 min. The methyl pivalate (J-I) (1 eq., 10 g) was added dropwise within 15 min and the reaction mixture was refluxed for 3 h. After complete reaction, the reaction mixture was placed in iced water (200 g), acidified to pH 4.5 and extracted with dichloromethane (12.x.250 ml). The combined organic phases were dried over sodium sulfate, distilled and after recrystallisation from hexane (100 ml) 5 g of the product (J-II) (51percent yield) was able to be obtained as a solid brown substance.
51%
Stage #1: With sodium hydride In 1,4-dioxane; paraffin oil for 0.75 h;
Stage #2: for 3 h; Reflux
NaH (50 percent in paraffin oil) (1.2 equivalents, 4.6 g) was dissolved in 1 ,4-dioxane (120 mL) and the mixture was stirred for a few minutes. Acetonitrile (1.2 equivalents, 4.2 g) was added dropwise within 15 min and the mixture was stirred for a further 30 min. The methyl pivalate (J-l) (1 equivalents, 10 g) was added dropwise within 15 min and the reaction mixture was refluxed for 3 h. After complete reaction, the reaction mixture was placed in iced water (200 g), acidified to pH 4.5 and extracted with dichloromethane (12 x 250 mL). The combined organic phases were dried over sodium sulphate, distilled and after recrystallisation from n-hexane (100 mL) 5 g of the product (J-ll) (51 percent yield) was able to be obtained as a solid brown substance.
51%
Stage #1: With sodium hydride In 1,4-dioxane; paraffin oil for 0.75 h;
Stage #2: for 3 h; Reflux
Step j02
NaH (50percent in paraffin oil) (1.2 equivalents, 4.6 g) was dissolved in 1,4-dioxane (120 mL) and the mixture was stirred for a few minutes.
Acetonitrile (1.2 equivalents, 4.2 g) was added dropwise within 15 min and the mixture was stirred for a further 30 min.
The methyl pivalate (J-I) (1 equivalents, 10 g) was added dropwise within 15 min and the reaction mixture was refluxed for 3 h.
After complete reaction, the reaction mixture was placed in iced water (200 g), acidified to pH 4.5 and extracted with dichloromethane (12*250 mL).
The combined organic phases were dried over sodium sulfate, distilled and after recrystallisation from n-hexane (100 mL) 5 g of the product (J-II) (51percent yield) was able to be obtained as a solid brown substance.
51%
Stage #1: With sodium hydride In 1,4-dioxane; paraffin oil for 0.75 h;
Stage #2: for 3.25 h; Reflux
NaH (50 percent in paraffin oil) (1 .2 equivalents, 4.6 g) was dissolved in 1 ,4-dioxane (120 mL) and the mixture was stirred for a few minutes. Acetonitrile (1 .2 equivalents, 4.2 g) was added dropwise within 15 min and the mixture was stirred for a further 30 min. The methyl pivalate (J-l) (1 equivalents, 10 g) was added dropwise within 15 min and the reaction mixture was refluxed for 3 h. After complete reaction, the reaction mixture was placed in iced water (200 g), acidified to pH 4.5 and extracted with dichloromethane (12 x 250 mL). The combined organic phases were dried over sodium sulphate, distilled and after recrystallisation from n-hexane (100 mL) 5 g of the product (J-ll) (51 percent yield) was able to be obtained as a solid brown substance.
51%
Stage #1: With sodium hydride In 1,4-dioxane; paraffin oil for 0.75 h;
Stage #2: for 3.25 h; Reflux
Step j02: NaH (50 percent in paraffin oil) (1 .2 equivalents, 4.6 g) was dissolved in 1 ,4-dioxane (120 mL) and the mixture was stirred for a few minutes. Acetonitrile (1 .2 equivalents, 4.2 g) was added dropwise within 15 min and the mixture was stirred for a further 30 min. The methyl pivalate (J-l) (1 equivalents, 10 g) was added dropwise within 15 min and the reaction mixture was refluxed for 3 h. After complete reaction, the reaction mixture was placed in iced water (200 g), acidified to pH 4.5 and extracted with dichloromethane (12 x 250 mL). The combined organic phases were dried over sodium sulphate, distilled and after recrystallisation from n-hexane (100 mL) 5 g of the product (J-ll) (51 percent yield) was able to be obtained as a solid brown substance.
51%
Stage #1: With sodium hydride In 1,4-dioxane; paraffin oil for 0.75 h;
Stage #2: for 3.25 h; Reflux
Step j02: NaH (50 percent in paraffin oil) (1 .2 equivalents, 4.6 g) was dissolved in 1 ,4-dioxane (120 mL) and the mixture was stirred for a few minutes. Acetonitrile (1 .2 equivalents, 4.2 g) was added dropwise within 15 min and the mixture was stirred for a further 30 min. The methyl pivalate (J-l) (1 equivalents, 10 g) was added dropwise within 15 min and the reaction mixture was refluxed for 3 h. After complete reaction, the reaction mixture was placed in iced water (200 g), acidified to pH 4.5 and extracted with dichloromethane (12 x 250 mL). The combined organic phases were dried over sodium sulphate, distilled and after recrystallisation from n-hexane (100 mL) 5 g of the product (J-ll) (51 percent yield) was able to be obtained as a solid brown substance.
51%
Stage #1: With sodium hydride In 1,4-dioxane; paraffin oil for 0.75 h;
Stage #2: for 3.25 h; Reflux
NaH (50 percent in paraffin oil) (1 .2 equivalents, 4.6 g) was dissolved in 1 ,4-dioxane (120 mL) and the mixture was stirred for a few minutes. Acetonitrile (1 .2 equivalents, 4.2 g) was added dropwise within 15 min and the mixture was stirred for a further 30 min. The methyl pivalate (J-l) (1 equivalents, 10 g) was added dropwise within 15 min and the reaction mixture was refluxed for 3 h. After complete reaction, the reaction mixture was placed in iced water (200 g), acidified to pH 4.5 and extracted with dichloromethane (12 x 250 mL). The combined organic phases were dried over sodium sulphate, distilled and after recrystallisation from n-hexane (100 mL) 5 g of the product (J-ll) (51 percent yield) was able to be obtained as a solid brown substance
51%
Stage #1: With sodium hydride In 1,4-dioxane; paraffin oil for 0.75 h;
Stage #2: for 3 h; Reflux
Step j02: NaH (50 percent in paraffin oil) (1 .2 equivalents, 4.6 g) was dissolved in 1 ,4-dioxane (120 mL) and the mixture was stirred for a few minutes. Acetonitrile (1 .2 equivalents, 4.2 g) was added dropwise within 15 min and the mixture was stirred for a further 30 min. The methyl pivalate (J-l) (1 equivalents, 10 g) was added dropwise within 15 min and the reaction mixture was refluxed for 3 h. After complete reaction, the reaction mixture was placed in iced water (200 g), acidified to pH 4.5 and extracted with dichloromethane (12 x 250 mL). The combined organic phases were dried over sodium sulphate, distilled and after recrystallisation from n-hexane (100 mL) 5 g of the product (J-ll) (51 percent yield) was able to be obtained as a solid brown substance.

Reference: [1] Tetrahedron, 1993, vol. 49, # 23, p. 5091 - 5098
[2] Journal of the Chemical Society, Chemical Communications, 1992, # 1, p. 50 - 51
[3] Patent: WO2010/127855, 2010, A1, . Location in patent: Page/Page column 95
[4] Patent: WO2010/127856, 2010, A1, . Location in patent: Page/Page column 78
[5] Patent: US2012/46301, 2012, A1, . Location in patent: Page/Page column 28; 29
[6] Patent: US2012/115903, 2012, A1, . Location in patent: Page/Page column 33
[7] Patent: WO2012/62462, 2012, A1, . Location in patent: Page/Page column 73
[8] Patent: US2012/115893, 2012, A1, . Location in patent: Page/Page column 29
[9] Patent: WO2013/13815, 2013, A1, . Location in patent: Page/Page column 104
[10] Patent: US2013/29962, 2013, A1, . Location in patent: Paragraph 0667
[11] Patent: WO2013/68463, 2013, A1, . Location in patent: Page/Page column 46
[12] Patent: WO2013/68461, 2013, A1, . Location in patent: Page/Page column 67
[13] Patent: WO2013/68467, 2013, A1, . Location in patent: Page/Page column 48
[14] Patent: WO2013/68464, 2013, A1, . Location in patent: Page/Page column 48
[15] Patent: WO2013/68462, 2013, A1, . Location in patent: Page/Page column 56
[16] Patent: WO2012/62463, 2012, A1, . Location in patent: Page/Page column 72
[17] Patent: WO2016/3827, 2016, A2, . Location in patent: Paragraph 0219
  • 7
  • [ 75-97-8 ]
  • [ 59997-51-2 ]
YieldReaction ConditionsOperation in experiment
85% With hydrogenchloride; sodium hydroxide; sodium bicarbonate; chlorine In methanol; water; benzene EXAMPLE 2
To a solution of pinacolone (100.16 g, 1 mol) in methanol (300 ml) is introduced gaseous chlorine (70.91 g, 1 mol) at 15-20° C. over a period of 1 hour.
The reaction mixture is neutralized with a 48percent solution of sodium hydroxide in methanol (285 ml) and then aqueous solution of sodium hydrogen carbonate (4.20 g) in that order.
After dilution with methanol (40 ml), the resulting mixture is mixed with an aqueous solution (137 ml) of sodium cyanide (58.81 g, 1.2 mol) and refluxed for 1 hour.
The methanol is evaporated under atmospheric pressure over a period of 1.5 hours.
The residue is mixed with a 4percent aqueous sodium hydroxide (650 g) solution and shaken with benzene (300 ml) to remove neutral material (10.78 g).
Hydrochloric acid (35percent) (92.60 g) is poured into said alkaline aqueous layer below 15° C., and the mixture is shaken with benzene (750 ml).
The benzene layer is washed with water, then mixed with an aqueous solution (44 ml) of sodium hydrogen carbonate (0.66 g), and the benzene layer is evaporated under atmospheric pressure.
A solution of the residue is adjusted to pH 7.0 by stirring with benzene (142 ml), water (30 ml) then 35percent hydrochloric acid (0.37 g).
The benzene layer is dried and concentrated to give cyanopinacolone (106.70 g) as crystals melting at 64° to 67° C.
Yield is 85 percent.
Reference: [1] Patent: US4186144, 1980, A,
[2] Chemische Berichte, 1911, vol. 44, p. 2071
  • 8
  • [ 773837-37-9 ]
  • [ 5469-26-1 ]
  • [ 59997-51-2 ]
Reference: [1] European Journal of Medicinal Chemistry, 2014, vol. 78, p. 294 - 303
[2] Tetrahedron Letters, 2019, vol. 60, # 1, p. 72 - 74
  • 9
  • [ 598-98-1 ]
  • [ 59997-51-2 ]
Reference: [1] Patent: US4716237, 1987, A,
[2] Patent: US4716237, 1987, A,
[3] Patent: US4416683, 1983, A,
[4] Patent: US4781750, 1988, A,
  • 10
  • [ 13547-70-1 ]
  • [ 59997-51-2 ]
Reference: [1] Patent: US4186144, 1980, A,
  • 11
  • [ 3282-30-2 ]
  • [ 372-09-8 ]
  • [ 59997-51-2 ]
Reference: [1] Synthesis, 1983, vol. No. 4, p. 308 - 309
[2] Patent: US5804532, 1998, A,
  • 12
  • [ 64214-60-4 ]
  • [ 75-05-8 ]
  • [ 59997-51-2 ]
Reference: [1] Organic and Biomolecular Chemistry, 2015, vol. 13, # 7, p. 1969 - 1973
  • 13
  • [ 773837-37-9 ]
  • [ 13547-70-1 ]
  • [ 59997-51-2 ]
Reference: [1] Organic Preparations and Procedures International, 2014, vol. 46, # 4, p. 386 - 389
  • 14
  • [ 3938-95-2 ]
  • [ 75-05-8 ]
  • [ 59997-51-2 ]
Reference: [1] Journal of Heterocyclic Chemistry, 1989, vol. 26, p. 1575 - 1578
[2] Journal of Medicinal Chemistry, 2008, vol. 51, # 15, p. 4672 - 4684
[3] Bioorganic and Medicinal Chemistry Letters, 2015, vol. 25, # 17, p. 3436 - 3441
[4] Journal of Medicinal Chemistry, 2016, vol. 59, # 18, p. 8293 - 8305
  • 15
  • [ 3282-30-2 ]
  • [ 59997-51-2 ]
Reference: [1] Patent: US2012/46301, 2012, A1,
[2] Patent: US2012/115903, 2012, A1,
[3] Patent: WO2012/62463, 2012, A1,
[4] Patent: WO2012/62462, 2012, A1,
[5] Patent: US2012/115893, 2012, A1,
[6] Patent: WO2013/13815, 2013, A1,
[7] Patent: US2013/29962, 2013, A1,
[8] Patent: WO2013/68463, 2013, A1,
[9] Patent: WO2013/68461, 2013, A1,
[10] Patent: WO2013/68467, 2013, A1,
[11] Patent: WO2013/68464, 2013, A1,
[12] Patent: WO2013/68462, 2013, A1,
  • 16
  • [ 1132-15-6 ]
  • [ 59997-51-2 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1976, p. 783 - 787
  • 17
  • [ 13547-70-1 ]
  • [ 143-33-9 ]
  • [ 59997-51-2 ]
Reference: [1] Nippon Kagaku Zasshi, 1957, vol. 78, p. 48[2] Chem.Abstr., 1959, vol. 53, # 5185,
  • 18
  • [ 13547-70-1 ]
  • [ 151-50-8 ]
  • [ 59997-51-2 ]
Reference: [1] Bulletin de la Societe Chimique de France, 1950, p. 1209,1216
  • 19
  • [ 151-50-8 ]
  • [ 5469-26-1 ]
  • [ 59997-51-2 ]
Reference: [1] Chemische Berichte, 1911, vol. 44, p. 2071
  • 20
  • [ 13547-70-1 ]
  • [ 151-50-8 ]
  • [ 59997-51-2 ]
Reference: [1] Gazzetta Chimica Italiana, 1948, vol. 78, p. 155,162
  • 21
  • [ 64-17-5 ]
  • [ 141-52-6 ]
  • [ 59997-51-2 ]
Reference: [1] Bulletin de la Societe Chimique de France, 1950, p. 1209,1216
  • 22
  • [ 59997-51-2 ]
  • [ 60-34-4 ]
  • [ 118430-73-2 ]
Reference: [1] Bioorganic and medicinal chemistry letters, 2002, vol. 12, # 12, p. 1559 - 1562
[2] Organic and Biomolecular Chemistry, 2006, vol. 4, # 22, p. 4158 - 4164
[3] Journal of Medicinal Chemistry, 2016, vol. 59, # 18, p. 8293 - 8305
[4] Chemical and Pharmaceutical Bulletin, 1987, vol. 35, # 8, p. 3235 - 3252
[5] Patent: US6338741, 2002, B1, . Location in patent: Page column 20
[6] Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 6, p. 1772 - 1777
[7] Journal of Medicinal Chemistry, 2012, vol. 55, # 3, p. 1082 - 1105
  • 23
  • [ 59997-51-2 ]
  • [ 32064-64-5 ]
  • [ 118430-73-2 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 16, p. 3928 - 3937
  • 24
  • [ 59997-51-2 ]
  • [ 118430-73-2 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 18, p. 4383 - 4388
  • 25
  • [ 59997-51-2 ]
  • [ 60-34-4 ]
  • [ 118430-73-2 ]
Reference: [1] MedChemComm, 2016, vol. 7, # 7, p. 1421 - 1428
  • 26
  • [ 59997-51-2 ]
  • [ 637-04-7 ]
  • [ 898537-77-4 ]
YieldReaction ConditionsOperation in experiment
90% at 80℃; General procedure: A solution of the corresponding substituted phenylhydrazine hydrochloride (1 equiv.) and pivaloylacetonitrile (1.2 equiv.) was stirred overnight at 80 °C in ethanol. The solution was extracted with EtOAc. The organic layer was washed with water and brine, dried (MgSO4), filtered, and evaporated to dryness.#10;#10;
79% With hydrogenchloride In ethanol for 48 h; Reflux General procedure: A solution of 4-tolyllhydrazine hydrochloride(5.20 g, 33 mmol) and pentylacyl acetonitrile (3.75 g, 30 mmol) in 0.4 M ethanolic solution of HCl(100 mL) was heated under reflux during 48 h. After cooling to room temperature, 1M NaOH wasadded to the mixture until the pH reached 10–11. The mixture was partitioned between water and ethylacetate. The water phase was extracted twice with dichloromethane. The organic phases werecombined and washed with water and brine, then dried with Na2SO4. Evaporation of the solvent invacuo afforded the crude product, which was subjected to recrystallization from ethyl acetate andpetroleum ether to produce compound 25a as a white solid (5.88 g, 86percent yield).
Reference: [1] Molecules, 2016, vol. 21, # 5,
[2] Molecules, 2014, vol. 19, # 2, p. 2004 - 2028
[3] Journal of Medicinal Chemistry, 2002, vol. 45, # 14, p. 2994 - 3008
[4] Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2013, vol. 52, # 6, p. 818 - 823
  • 27
  • [ 59997-51-2 ]
  • [ 536-89-0 ]
  • [ 898537-77-4 ]
Reference: [1] Journal of Medicinal Chemistry, 2009, vol. 52, # 13, p. 3915 - 3926
[2] Journal of the American Chemical Society, 2009, vol. 131, # 37, p. 13286 - 13296
[3] Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 6, p. 1772 - 1777
[4] Patent: US2009/131437, 2009, A1, . Location in patent: Page/Page column 21
[5] MedChemComm, 2016, vol. 7, # 7, p. 1421 - 1428
  • 28
  • [ 59997-51-2 ]
  • [ 637-60-5 ]
  • [ 285984-25-0 ]
YieldReaction ConditionsOperation in experiment
86% With hydrogenchloride In ethanol for 48 h; Reflux A solution of 4-tolyllhydrazine hydrochloride(5.20 g, 33 mmol) and pentylacyl acetonitrile (3.75 g, 30 mmol) in 0.4 M ethanolic solution of HCl(100 mL) was heated under reflux during 48 h. After cooling to room temperature, 1M NaOH wasadded to the mixture until the pH reached 10–11. The mixture was partitioned between water and ethylacetate. The water phase was extracted twice with dichloromethane. The organic phases werecombined and washed with water and brine, then dried with Na2SO4. Evaporation of the solvent invacuo afforded the crude product, which was subjected to recrystallization from ethyl acetate andpetroleum ether to produce compound 25a as a white solid (5.88 g, 86percent yield).
86.4% With hydrogenchloride In ethanol at 80℃; for 8 h; A solution of 4-tolyllhydrazine hydrochloride (5.20 g,33 mmol) and pentylacyl acetonitrile (3.75 g, 30 mmol) in 0.4 M ethanolic solution of HCl (100 mL)was heated under reflux during 8 h. After cooling to room temperature, 1 M NaOH was added to the mixture until the pH reached 10–11. The mixture was partitioned between water and ethyl acetate. The water phase was extracted twice with dichloromethane. The organic phases were combined and washed with water and brine, then dried with Na2SO4. Evaporation of the solvent in vacuo afforded the crude product, which was subjected to recrystallization from ethyl acetate and petroleum ether to produce compound 2a as a white solid (5.88 g,). Yield: 86.4percent. 1H-NMR (CDCl3, 400 MHz), δ: 7.40 (d, 2H),7.25 (d, 2H), 5.50 (s, 1H), 4.72 (brs, 2H), 2.37 (s, 3H), 1.32 (s, 9H). ESI-MS (+Q, m/z): 230 [M + H]+,252 [M + Na]+.
52% With hydrogenchloride In ethanol; waterReflux Intermediate A: 3-tert-Butyl-1-p-tolyl-1H-pyrazol-5-amine
To a stirred solution of p-tolylhydrazine hydrochloride (100 g, 630 mmol) in EtOH (1251 mL) was added 4,4-dimethyl-3-oxopentanenitrile (88 g, 699 mmol) and HCl (62.5 mL, 750 mmol).
The resulting mixture was stirred at reflux overnight.
The reaction mixture was cooled to room temperature and concentrated in vacuo to c.a. 1/3 of the original volume.
The reaction mixture was then cooled in an ice-bath and taken to c.a. pH 8-9 with 6M aq NaOH.
The reaction mixture was extracted with diethyl ether (500 mL) and the organic phase washed with water (2*300 mL) before being dried over magnesium sulphate and concentrated in vacuo to afford an orange solid.
The solid was suspended in iso-hexane and stirred at reflux for 2.5 h before being cooled and filtered whilst still hot to yield the subtitle product 3-tert-butyl-1-p-tolyl-1H-pyrazol-5-amine as a pale brown solid (76.5 g, 52percent); Rt 1.31 min (Method 1); m/z 230 (M+H)+ (ES+); 1H NMR δ: 1.20 (9H, s), 2.32 (3H, s), 5.10 (2H, br s), 5.35 (1H, s), 7.24 (2H, d), 7.42 (2H, m).
30 g for 1.5 h; Pivaloylacetonitrile (19.0 g) was refluxed with tolylhydrazine hydrochloride (24.0 g) in ethanol (190 ml) for 1.5 hr. The solution was cooled and volatiles removed in vacuo. The residue was extracted with ethyl acetate and 10percent aq. sodium carbonate, and the organic layer washed with water and brine. Drying over sodium sulfate and solvent removal afforded pyrazole 6 as an off-white solid (30 g).

Reference: [1] Patent: US2004/192653, 2004, A1,
[2] Molecules, 2014, vol. 19, # 2, p. 2004 - 2028
[3] Molecules, 2015, vol. 20, # 9, p. 16604 - 16619
[4] Organic Process Research and Development, 2010, vol. 14, # 3, p. 650 - 656
[5] Journal of the American Chemical Society, 2009, vol. 131, # 37, p. 13286 - 13296
[6] Organic Process Research and Development, 2011, vol. 15, # 4, p. 841 - 854
[7] Patent: US2015/232450, 2015, A1, . Location in patent: Paragraph 0205-0206
[8] Journal of Medicinal Chemistry, 2002, vol. 45, # 14, p. 2994 - 3008
[9] Patent: US2008/207647, 2008, A1, . Location in patent: Page/Page column 18
[10] Patent: US2015/183777, 2015, A1, . Location in patent: Paragraph 0191; 0192
[11] Molecules, 2016, vol. 21, # 5,
  • 29
  • [ 59997-51-2 ]
  • [ 539-44-6 ]
  • [ 285984-25-0 ]
YieldReaction ConditionsOperation in experiment
80.3% With hydrogenchloride In ethanol for 8 h; Reflux In a 250 mL pre-flask was added 100 mL of ethanol,(30 mmol) of pivaloylacetonitrile,(33. 63 mmol) of 4-methylphenylhydrazine,3. 6 mL of concentrated hydrochloric acid was added dropwise with stirring, heated under reflux for 8 hours,Cooled, concentrated, the residue adjusted with dilute sodium hydroxide PH10-11,Extracted three times with ethyl acetate, dried over anhydrous sodium sulfate, concentrated,The resulting solid was recrystallized from ethyl acetate / petroleum ether to give white crystals C,Yield 80.3percent. 5-tert-butyl-2-p-methylphenyl-3-aminopyrazole (3. 5 mmolC) was placed in 100 ml three-necked flask and dissolved in 30 ml of tetrahydrofuran. The three-necked flask was allowed to cool to -20 ° C, stirring in batches by adding 2. 9g sodium bicarbonate, 15min, dropwise dropwise chloroformic acid trichloroethyl ester(3. 5 mmol),Control solution temperature does not exceed ° C,After completion of the dropwise addition, the mixture was stirred for 30 min and then heated to 0 ° C for 12 h. After completion of the reaction, the mixture was filtered and the residue was rinsed with ethyl acetate and the filtrate was concentrated to yield 85percent.
80.3% With hydrogenchloride In ethanol; water for 8 h; Reflux In a 250 mL round botom flask, 100 mL of ethanol was added, (30 mmol) of pivaloylacetonitrile, (33.63 mmol) of 4-methylphenylhydrazine, A solution of 3.6 mL of concentrated hydrochloric acid was added dropwise with stirring,Heated to reflux for 8 hours, cool down, concentrate, The residue was adjusted to pH 10-11 with dilute sodium hydroxide, Extracted three times with ethyl acetate, Dried over anhydrous sodium sulfate, concentrate, The resulting solid was recrystallized from ethyl acetate / petroleum ether to give white crystals C, Yield 80.3percent. 5-tert-butyl-2-p-methylphenyl-3-aminopyrazole (3.5 mmolC) was placed in a 100 ml three-Dissolved in 30 ml of tetrahydrofuran, Place the three-necked flask in a cryogenic tank to cool to -20 ° C, 2.9 g of sodium bicarbonate was added in portions with stirring, After 15 min, A solution of trichloroethyl chloroformate (3.5 mmol) was added dropwise, Control the solution temperature does not exceed 0 deg C, After dripping, Continue stirring for 30min, And then heated to 0 ° C for 12 h. After completion of the reaction, The mixture is filtered, The residue was washed with ethyl acetate, The filtrate was concentrated, Yield 85percent.
80.3% for 8 h; Reflux In 250 ml bottle eggplant adding 100 ml ethanol, (30mmol) special fifth heavenly stem acyl acetonitrile, (33.63mmol) 4 - methyl phenyl hydrazine, stirring next adds by drops 3.6 ml concentrated hydrochloric acid, heating reflux for 8 hours, cooling, concentrated, the residue with dilute sodium hydroxide to adjust the pH 10 - 11, ethyl acetate extraction three times, dried with anhydrous sodium sulfate, concentrated, the obtained solid ethyl acetate/petroleum ether recrystallization to obtain white crystal C, yield 80.3percent. 5 - tert-butyl -2 - methylphenyl -3 - amino pyrazole (3.5mmolC) in 100 ml in three-necked bottle, to 30 ml tetrahydrofuran is dissolved, the low temperature troughthree-necked bottle is lowering the temperature to -20 °C, stirring in batches under the adding 2.9g sodium bicarbonate, 15min after, little by chlorination formic acid trichloroethyl (3.5mmol), control solution at a temperature of not more than 0 °C, after dropping, continuing to stir 30min, then heating up to 0 °C reaction 12h. The completion of the reaction, the mixture filtration, the filter residue washed ethyl acetate, the filtrate is concentrated, yield 85percent.
Reference: [1] Patent: CN106518767, 2017, A, . Location in patent: Paragraph 0075; 0076; 0115
[2] Patent: CN106518766, 2017, A, . Location in patent: Paragraph 0098
[3] Patent: CN106518858, 2017, A, . Location in patent: Paragraph 0076
[4] Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 6, p. 1772 - 1777
[5] Patent: US2009/131437, 2009, A1, . Location in patent: Page/Page column 15
[6] Patent: EP1698335, 2006, A1, . Location in patent: Page/Page column 42
[7] Bioorganic and Medicinal Chemistry Letters, 2013, vol. 23, # 19, p. 5401 - 5409
[8] MedChemComm, 2016, vol. 7, # 7, p. 1421 - 1428
  • 30
  • [ 59997-51-2 ]
  • [ 285984-25-0 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 18, p. 4383 - 4388
  • 31
  • [ 59997-51-2 ]
  • [ 24424-99-5 ]
  • [ 637-60-5 ]
  • [ 285983-48-4 ]
Reference: [1] Patent: US6492529, 2002, B1,
  • 32
  • [ 59997-51-2 ]
  • [ 285983-48-4 ]
Reference: [1] Journal of Medicinal Chemistry, 2002, vol. 45, # 14, p. 2994 - 3008
[2] Patent: US2012/184735, 2012, A1,
  • 33
  • [ 59997-51-2 ]
  • [ 1020172-07-9 ]
Reference: [1] Patent: WO2013/36232, 2013, A2,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 59997-51-2 ]

Aliphatic Chain Hydrocarbons

Chemical Structure| 29509-06-6

[ 29509-06-6 ]

4-Methyl-3-oxopentanenitrile

Similarity: 0.95

Chemical Structure| 37719-02-1

[ 37719-02-1 ]

2,2-Dimethyl-3-oxobutanenitrile

Similarity: 0.91

Chemical Structure| 2469-99-0

[ 2469-99-0 ]

3-Oxobutanenitrile

Similarity: 0.76

Chemical Structure| 5722-11-2

[ 5722-11-2 ]

2,2-Dimethylcyclopropanecarbonitrile

Similarity: 0.57

Chemical Structure| 13706-86-0

[ 13706-86-0 ]

5-Methylhexane-2,3-dione

Similarity: 0.54

Ketones

Chemical Structure| 29509-06-6

[ 29509-06-6 ]

4-Methyl-3-oxopentanenitrile

Similarity: 0.95

Chemical Structure| 37719-02-1

[ 37719-02-1 ]

2,2-Dimethyl-3-oxobutanenitrile

Similarity: 0.91

Chemical Structure| 118431-88-2

[ 118431-88-2 ]

3-Cyclopropyl-3-oxopropanenitrile

Similarity: 0.87

Chemical Structure| 2941-29-9

[ 2941-29-9 ]

Cyclopentanone-2-carbonitrile

Similarity: 0.83

Chemical Structure| 2469-99-0

[ 2469-99-0 ]

3-Oxobutanenitrile

Similarity: 0.76

Nitriles

Chemical Structure| 29509-06-6

[ 29509-06-6 ]

4-Methyl-3-oxopentanenitrile

Similarity: 0.95

Chemical Structure| 37719-02-1

[ 37719-02-1 ]

2,2-Dimethyl-3-oxobutanenitrile

Similarity: 0.91

Chemical Structure| 118431-88-2

[ 118431-88-2 ]

3-Cyclopropyl-3-oxopropanenitrile

Similarity: 0.87

Chemical Structure| 2941-29-9

[ 2941-29-9 ]

Cyclopentanone-2-carbonitrile

Similarity: 0.83

Chemical Structure| 2469-99-0

[ 2469-99-0 ]

3-Oxobutanenitrile

Similarity: 0.76